CD3 FITC/CD8 R-PE MONOCLONAL ANTIBODY COMBINATION— 510(k) K950916

Substantially Equivalent

Caltag Laboratories, Inc.

FDA 510(k) clearance K950916 for CD3 FITC/CD8 R-PE MONOCLONAL ANTIBODY COMBINATION, Substantially Equivalent on 1995-12-21. Applicant: Caltag Laboratories, Inc..

Clearance details

Applicant: Caltag Laboratories, Inc.
Product code: Code GKZ
Advisory panel: Hematology
Date received: 1995-03-01
Decision date: 1995-12-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: South San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code GKZ

product code GKZ

Malfunction: 1,205
Total: 1,205

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.